Sheng Cai
@shengfcai
Followers
781
Following
4K
Statuses
588
physician-scientist @MSKCancerCenter All views expressed here are my own & do not represent my employer.
New York, NY
Joined December 2013
RT @GhayasIssa: Menin inhibition is a standard of care! FDA approval of revumenib!! So happy to see that the benefit witnessed in patients…
0
39
0
RT @MCThompsonMD: Roeker et al. MRD guided duration of ven + obin in previously untx CLL. 90% of pts with high pre tx TLS converted to low…
0
10
0
RT @EricTopol: 15 years after the 1st sequence of a cancer genome "Today, genomic sequencing as part of clinical ca…
0
84
0
So fortunate to have the privilege of writing this N&V with @rosslevinemd to commemorate the 15th anniversary of the first cancer genome spearheaded by Tim and the WashU group. I've been mentored by the absolute best.
The first genome sequence of a human cancer was reported 15 years ago. As @shengfcai & @rosslevinemd discuss, this ushered in a new era of diagnostic, prognostic and therapeutic advances.
3
9
60
RT @DukeMedSchool: A host of luminaries, including seven Nobel Laureates, two former chancellors, and scores of Robert J. Lefkowitz’s forme…
0
10
0
Thank you @TheMarkFdn for your support and for allowing me to attend this amazing meeting! Truly honored to receive the Wogan Prize!
Congratulations to Aspen Fellow (& former Mark Foundation Momentum Fellow) @ShengFCai for winning the Holly & Gerald N. Wogan prize! Mentored by @rosslevinemd, Dr. Cai is a Leukemia Specialist at @MSKCancerCenter
8
3
55
RT @MSKCancerCenter: Please join us in congratulating Dr. @AbdelWahablab on being named the William Dameshek Prize winner by @ASH_hematolog…
0
21
0
1
0
2
RT @CD_AACR: Read this week's Cancer Discovery #ResearchWatch: Revumenib Is Safe and Efficacious, but #MEN1 Mutations Mediate Resistance, a…
0
6
0
RT @mvicaracal: Online at @nature two papers on menin inhibitors: Phase I trial and dissection of resistance https:…
0
7
0
@dstarczynowski @rosslevinemd @Armstrong_dfci @florian_perner @jchodera @fischerlab1 @sukritsingh92 Thanks Dan!
0
0
0
@diunguyen_vn_uk @rosslevinemd @Armstrong_dfci @florian_perner @jchodera @fischerlab1 @sukritsingh92 Thanks Diu!
0
0
0
@MariaSirenko @rosslevinemd @Armstrong_dfci @florian_perner @jchodera @fischerlab1 @sukritsingh92 Thanks Maria!
0
0
0
@MDUppal92 @rosslevinemd @Armstrong_dfci @florian_perner @jchodera @fischerlab1 @sukritsingh92 Thanks Munna!
0
0
0
@FionnualaCrowle @rosslevinemd @Armstrong_dfci @florian_perner @jchodera @fischerlab1 @sukritsingh92 Thanks Finn!
0
0
0
@TaylorJ_MD @rosslevinemd @Armstrong_dfci @florian_perner @jchodera @fischerlab1 @sukritsingh92 Thanks Justin!
0
0
1
@Vuphuongly @rosslevinemd @Armstrong_dfci @florian_perner @jchodera @fischerlab1 @sukritsingh92 Thanks Ly!
0
0
0
RT @florian_perner: Happy to share our story out today in @Nature on novel point mutations in MEN1 that cause resistance to #Menin inhobito…
0
38
0